• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

掌跖脓疱病:发病机制和新兴治疗方法的最新进展。

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.

机构信息

Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008, Warsaw, Poland.

出版信息

Am J Clin Dermatol. 2020 Jun;21(3):355-370. doi: 10.1007/s40257-020-00503-5.

DOI:10.1007/s40257-020-00503-5
PMID:32008176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7275027/
Abstract

Palmoplantar pustulosis (PPP) is a chronic, recurrent skin disease belonging to the spectrum of psoriasis. It is characterized by an eruption of sterile pustules on the palms and soles. Recent studies in PPP have focused on genetic differences between pustular phenotypes and the role of the innate immunological system and the microbiome in the etiopathogenesis of the disease. Mutations in IL36RN (a major predisposing factor for generalized pustular psoriasis) were found in selected patients with PPP and were associated with earlier disease onset. Studies have shown that the interleukin (IL)-17 and IL-36 pathways might be involved in the pathogenesis of PPP. A microbiome has been demonstrated in the vesicopustules of PPP, and an abundance of Staphylococcus appears to be increased by smoking. Improved understanding of the underlying etiopathogenesis of PPP has led to advances in treatment options, and targeted therapies for PPP have been evaluated or are under evaluation against more than 12 molecules in ongoing clinical trials. These targets include CXCR2 (IL-8 receptor type B), granulocyte colony-stimulating factor receptor, IL-1 receptor, IL-8, IL-12, IL-23, IL-17A, IL-17 receptor, IL-36 receptor, phosphodiesterase-4, and tumor necrosis factor-α.

摘要

掌跖脓疱病 (PPP) 是一种慢性、复发性皮肤病,属于银屑病谱。其特征是手掌和脚底出现无菌脓疱。近期 PPP 的研究集中在脓疱表型之间的遗传差异以及固有免疫系统和微生物组在疾病发病机制中的作用。在选定的 PPP 患者中发现了 IL36RN(泛发性脓疱性银屑病的主要易感因素)突变,与疾病更早发作相关。研究表明,白细胞介素 (IL)-17 和 IL-36 通路可能参与 PPP 的发病机制。PPP 的水疱脓疱中存在微生物组,而吸烟似乎会增加金黄色葡萄球菌的丰度。对 PPP 潜在发病机制的深入了解导致治疗选择的进步,针对超过 12 种分子的靶向治疗已在进行中的临床试验中进行了评估或正在评估。这些靶点包括 CXCR2(IL-8 受体类型 B)、粒细胞集落刺激因子受体、IL-1 受体、IL-8、IL-12、IL-23、IL-17A、IL-17 受体、IL-36 受体、磷酸二酯酶-4 和肿瘤坏死因子-α。

相似文献

1
Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.掌跖脓疱病:发病机制和新兴治疗方法的最新进展。
Am J Clin Dermatol. 2020 Jun;21(3):355-370. doi: 10.1007/s40257-020-00503-5.
2
Therapeutic options for palmoplantar pustulosis.掌跖脓疱病的治疗选择。
Clin Exp Dermatol. 2010 Apr;35(3):219-22. doi: 10.1111/j.1365-2230.2009.03520.x. Epub 2009 Oct 23.
3
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.脓疱型银屑病:病理生理学与治疗选择最新进展的叙述性综述
Dermatol Ther (Heidelb). 2021 Dec;11(6):1917-1929. doi: 10.1007/s13555-021-00612-x. Epub 2021 Oct 9.
4
Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations.掌跖脓疱病(PPP)患者的诊断、筛查与治疗:当前实践与建议综述
Clin Cosmet Investig Dermatol. 2020 Aug 14;13:561-578. doi: 10.2147/CCID.S240607. eCollection 2020.
5
Recent advances in palmoplantar pustulosis.掌跖脓疱病的最新进展
Fac Rev. 2021 Jul 27;10:62. doi: 10.12703/r/10-62. eCollection 2021.
6
Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.掌跖脓疱病:对疾病定义和发病机制的当前认识
J Dermatol Sci. 2020 Apr;98(1):13-19. doi: 10.1016/j.jdermsci.2020.03.003. Epub 2020 Mar 14.
7
Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial.用阿那白滞素治疗脓疱性银屑病:一项适应性两阶段随机安慰剂对照试验第 1 阶段的统计分析计划。
Trials. 2018 Oct 3;19(1):534. doi: 10.1186/s13063-018-2914-y.
8
Palmoplantar Pustulosis: Therapy Update.掌跖脓疱病:治疗进展。
J Drugs Dermatol. 2024 Aug 1;23(8):626-631. doi: 10.36849/JDD.7612.
9
Palmoplantar pustulosis - a cross-sectional analysis in Germany.掌跖脓疱病——德国的一项横断面分析
Dermatol Online J. 2017 Apr 15;23(4):13030/qt0h15613d.
10
A brief guide to pustular psoriasis for primary care providers.为初级保健提供者提供的脓疱性银屑病简要指南。
Postgrad Med. 2021 Apr;133(3):330-344. doi: 10.1080/00325481.2020.1831315. Epub 2020 Oct 29.

引用本文的文献

1
Psoriasis.银屑病
Nat Rev Dis Primers. 2025 Jun 26;11(1):45. doi: 10.1038/s41572-025-00630-5.
2
Determination of Risk Factors Influencing Psoriatic Arthritis Screening and Evaluation Questionnaire Scores in Palmoplantar Pustulosis: Post Hoc Analysis of EPPPIK Study.掌跖脓疱病中影响银屑病关节炎筛查与评估问卷分数的危险因素的确定:EPPPIK研究的事后分析
Dermatol Ther (Heidelb). 2025 Jun 23. doi: 10.1007/s13555-025-01460-9.
3
Novel Findings on the Development and Immunological Functions of Palatine Tonsils.腭扁桃体发育及免疫功能的新发现
Clin Rev Allergy Immunol. 2025 Jun 18;68(1):58. doi: 10.1007/s12016-025-09071-0.
4
Short-Term Relief with Upadacitinib: A Case Report of Palmoplantar Pustulosis in a Pediatric Patient.乌帕替尼带来的短期缓解:一名儿科掌跖脓疱病患者的病例报告
Clin Cosmet Investig Dermatol. 2025 Apr 3;18:797-800. doi: 10.2147/CCID.S494567. eCollection 2025.
5
Correlation between pierced earrings and the prevalence of metal allergies at Tokushima university hospital: a 15-year retrospective analysis.德岛大学医院穿孔耳环与金属过敏患病率的相关性:一项15年回顾性分析
Sci Rep. 2025 Mar 29;15(1):10939. doi: 10.1038/s41598-025-86868-1.
6
Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib.病例报告:乌帕替尼成功治疗难治性掌跖脓疱病
Front Immunol. 2025 Mar 10;16:1476584. doi: 10.3389/fimmu.2025.1476584. eCollection 2025.
7
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review.德卡伐替尼在银屑病之外不断扩展的治疗潜力:一篇叙述性综述。
J Clin Med. 2025 Mar 5;14(5):1745. doi: 10.3390/jcm14051745.
8
Palmoplantar Pustulosis as an Immune-Mediated Inflammatory Disease with a Possible Relevance of Th17 Cell Plasticity: A Narrative Review.掌跖脓疱病作为一种免疫介导的炎症性疾病,可能与Th17细胞可塑性相关:一项叙述性综述。
Dermatol Ther (Heidelb). 2025 Apr;15(4):797-810. doi: 10.1007/s13555-025-01382-6. Epub 2025 Mar 15.
9
Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study).古塞库单抗治疗欧洲掌跖脓疱病患者的疗效和安全性:一项多中心、单臂临床试验(GAP研究)。
JAAD Int. 2024 Oct 2;18:69-78. doi: 10.1016/j.jdin.2024.09.001. eCollection 2025 Feb.
10
Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options.掌跖脓疱病的实践模式:患者人口统计学特征及治疗选择
J Psoriasis Psoriatic Arthritis. 2022 Jul;7(3):117-121. doi: 10.1177/24755303221099292. Epub 2022 May 6.

本文引用的文献

1
Interventions for chronic palmoplantar pustulosis.慢性掌跖脓疱病的干预措施。
Cochrane Database Syst Rev. 2020 Jan 20;1(1):CD011628. doi: 10.1002/14651858.CD011628.pub2.
2
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial.古塞库单抗治疗日本掌跖脓疱病患者的疗效和安全性:一项3期随机临床试验。
JAMA Dermatol. 2019 Oct 1;155(10):1153-1161. doi: 10.1001/jamadermatol.2019.1394.
3
Palmoplantar Pustulosis and Allergies: A Systematic Review.掌跖脓疱病与过敏:一项系统综述
Dermatol Pract Concept. 2019 Apr 30;9(2):105-110. doi: 10.5826/dpc.0902a05. eCollection 2019 Apr.
4
Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx.掌跖脓疱病与汗疱疹的诊断组织病理学特征鉴别。
J Dermatol. 2019 May;46(5):399-408. doi: 10.1111/1346-8138.14850. Epub 2019 Mar 28.
5
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.抑制白细胞介素-36通路治疗泛发性脓疱型银屑病。
N Engl J Med. 2019 Mar 7;380(10):981-983. doi: 10.1056/NEJMc1811317.
6
Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.白介素-17 受体 A 阻断剂布罗利尤单抗治疗掌跖脓疱性银屑病:四例报告。
J Dermatol. 2019 May;46(5):426-430. doi: 10.1111/1346-8138.14815. Epub 2019 Feb 20.
7
A novel CARD14 variant, homozygous c.526G>C (p.Asp176His), in an adolescent Japanese patient with palmoplantar pustulosis.一名患有掌跖脓疱病的日本青少年患者中发现一种新的CARD14变异体,纯合子c.526G>C(p.Asp176His)。
Clin Exp Dermatol. 2019 Aug;44(6):694-696. doi: 10.1111/ced.13926. Epub 2019 Feb 5.
8
Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study.司库奇尤单抗治疗中重度掌跖脓疱型银屑病:2PRECISE 研究结果。
J Am Acad Dermatol. 2019 May;80(5):1344-1352. doi: 10.1016/j.jaad.2019.01.066. Epub 2019 Feb 1.
9
Dysbiosis of oral microbiota in palmoplantar pustulosis patients.掌跖脓疱病患者口腔微生物群失调
J Dermatol Sci. 2019 Jan;93(1):67-69. doi: 10.1016/j.jdermsci.2018.12.003. Epub 2019 Jan 2.
10
Dental metal allergy is not the main cause of palmoplantar pustulosis.牙齿金属过敏不是掌跖脓疱病的主要病因。
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e180-e181. doi: 10.1111/jdv.15434. Epub 2019 Feb 18.